ArticleJournal of virology2000

Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.

W P Halford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.